Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Dr Bianca Ogden and Hashan De Silva share the companies and trials they find interesting in the constantly innovating biotech ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

Pengana High Conviction Equities Fund portfolio manager James McDonald reckons these three biotechs are primed for growth.

Sana Biotechnology Inc (SANA) stock saw a modest uptick, ending the day at $4.62 which represents a slight increase of $0.33 or 7.69% from the prior close of $4.29. The stock opened at $4.47 and ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals (NASDAQ: VNDA). The commercial-stage ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...

Announced positive clinical results from BRACELET-1, its randomized Phase 2 study evaluating pelareorep in patients with HR+/HER2- advanced or metastatic breast cancer, reinforcing path to funding of ...